Treatment for patients with type 3 von Willebrand disease and alloantibodies: A case report

Haemophilia

Volumn 14, Issue 3, 2008, Pages 645-646

  Franchini, Massimo ^a,c   Gandini, G ^a   Giuffrida, A ^a   De Gironcoli, M ^a   Federici, A B ^b  

^a City Hosp   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Ospedale Policlinico   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; STEROID; VON WILLEBRAND FACTOR;

ABDOMINAL PAIN; ADULT; ALLOIMMUNITY; ANAPHYLAXIS; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLEEDING; BOLUS INJECTION; CASE REPORT; CLINICAL FEATURE; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG WITHDRAWAL; FEMALE; HEMATOMA; HEMATURIA; HUMAN; KIDNEY COLIC; MENORRHAGIA; PRIORITY JOURNAL; RETREATMENT; SUBSTITUTION THERAPY; TREATMENT DURATION; TREATMENT RESPONSE; VON WILLEBRAND DISEASE;

ADULT; ANAPHYLAXIS; ANTIGENS; COAGULANTS; FACTOR VIII; FEMALE; HUMANS; ISOANTIBODIES; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 43149111831     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01668.x     Document Type: Article

References (5)

1. Mannucci PM, Meyer D, Ruggeri ZM, Koutts J, Ciavarella N, Lavergne JM. Precipitating antibodies in von Willebrand's disease. Nature 1976; 262: 141-2.
2. Mannucci PM, Ruggeri ZM, Ciavarella N, Kazatchkine MD, Mowbray JF. Precipitating antibodies to factor VIII/von Willebrand factor in von Willebrand's disease: Effects on replacement therapy. Blood 1981; 57: 25-31.
3. Mannucci PM, Tamaro G, Narchi G et al. Life-threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor. Eur J Haematol 1987; 39: 467-70.
4. Griffith M, Kingdon H, Liu SL, Burkart W. In-process controls and characterization of recombinate antihemophilic factor (recombinant). Ann Hematol 1991; 63: 166-71.
5. Ciavarella N, Schiavoni M, Valenzano E, Mangini F, Inchingolo F. Use of recombinant factor VIIa (NovoSeven) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor. Haemostasis 1996; 26 (Suppl. 1): 150-4.